We read with interest the recent publication by Guo et al. [1] where they describe the identification and characterization of Osteopontin (OPN), Macrophage Migration Inhibitory (MIF), and anti-interleukin-8 autoantibodies as markers for early detection of ovarian cancer. This evidence concerns the gene SPP1 and ovarian carcinoma.